Medistim — Earnings Release 2016

Aug 24, 2016

Results for second quarter and the first half 2016 for Medistim ASA

Results for second quarter and the first half 2016 for Medistim ASA

Sales ended at MNOK 67.2 for the quarter (MNOK 57.3),

a 17.4 % growth. Currency neutral growth of own

products was 12.2 %. Sales for the 1st half increased

by 15.2 % and ended at MOK 132.7 (MNOK 115.2).

Currency neutral growth of own products was 15.1 %.

Operating profit (EBIT) for the quarter ended at MNOK

17.1 (MNOK 11.7). Operating profit for the 1st half

ended at MNOK 30.6 (MNOK 21.6). Profit per share

increased with 19 % for the quarter and ended at NOK

0.69 (NOK 0.58)

A new all time high quarter in USA with a 10.9 %

growth in sales, while currency neutral growth was

5.9%.

For the first half the growth was 24.9 % with a

currency neutral growth of 14.3 %.

Important milestone for Medistim ASA during the

quarter was that Medistim's technology has achieved

reimbursement in Japan.

Dividend based upon 2015 results was paid in the 2nd

quarter with MNOK 30.0, NOK 1.65 per share (NOK 1.40

per share).